El trading conlleva riesgos
Las inversiones conllevan riesgos y no son adecuadas para todos los inversores. Los CFDs son instrumentos complejos y tienen un alto riesgo de perder dinero rápidamente debido al apalancamiento.
El trading conlleva riesgos
Las inversiones conllevan riesgos y no son adecuadas para todos los inversores. Los CFDs son instrumentos complejos y tienen un alto riesgo de perder dinero rápidamente debido al apalancamiento.
Español (Latinoamérica)
Cytek Biosciences Inc
Cerrado
SectorSalud
3.79 1.61
Resumen
Variación precio
24h
Mínimo
3.68
Máximo
3.88
Ingresos | 8.7M 9.6M |
|---|---|
Ventas | 6M 57M |
BPA | 0.116 |
Margen de beneficio | 16.777 |
Empleados | 648 |
EBITDA | -5.5M -2.5M |
Recomendaciones | Neutral |
|---|---|
Estimación a 12 meses | +91.15% upside |
Próximas Ganancias | 5 ago 2025 |
|---|
Capitalización de Mercado | -180M 493M |
|---|---|
Apertura anterior | 2.18 |
Cierre anterior | 3.79 |
Noticias sobre sentimiento de mercado
By Acuity
50%
50%
195 / 382 Clasificación en Healthcare
Puntuación técnica
By Trading Central
Confianza
Weak Bullish Evidence
Cytek Biosciences Inc Gráfico
El rendimiento pasado no es un indicador fiable de resultados futuros.
Noticias Relacionadas
Comparación entre iguales
Cambio de precio
Cytek Biosciences Inc Esperado
Precio Objetivo
By TipRanks
91.15% repunte
Estimación a 12 meses
Media 7.13 USD 91.15%
Máximo 9 USD
Mínimo 4.5 USD
De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Cytek Biosciences Inc Dist en los últimos 3 meses.
Sentimiento
By Acuity
195 / 382 Clasificación en Salud
Noticias sobre sentimiento de mercado
Neutral
Volatilidad
Por debajo de la media
Volumen de Noticias (RCV)
Media
Finanzas
Gastos de venta y administración
Gastos operativos
Beneficio antes de impuestos
Ventas
Coste de ventas
Beneficio bruto de ventas
Gasto por intereses de deuda
EBITDA
Beneficio operativo
$
Acerca de Cytek Biosciences Inc
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
